Founded in 2022, Curapod operates in Health Tech offering a non-invasive pain relief device that utilises photobiomodulation technology to target pain and promote healing at the cellular level. The de...
Funding stage:
Pre-Series A
Last funding:
09/02/2026
Total funding:
$2.21 Mn+
Revenue:
Investors
Employee count:
47
Last 90d
47
Last 90d
Web traffic:
59K
59K
Last 30d
Last 30d
Curapod: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders29
Latest Filing Date02 Feb 2026- Funding Events25
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Curapod
As of 03 February 2026, Curapod's equity is held by 28 shareholders, with the top three being Surya Maguluri, V Cube Ventures SA, and Velliyur Sriram.
Surya Maguluri holds the largest stake in Curapod at 19.5% as of 03 February 2026.
As of 03 February 2026, founders collectively hold 31.4% equity in Curapod.
As of 03 February 2026, investors collectively hold 42.6% equity in Curapod.
Curapod's ESOP pool stands at 8.6% of total equity as of 03 February 2026.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links